Recent Finacing
Recent Raise
Synendos Therapeutics develops endocannabinoid reuptake inhibitors targeting a newly identified endocannabinoid-system protein to restore CNS endocannabinoid levels for anxiety, mood, and stress-related disorders; preclinical University of Bern spinout.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
